InsiderClue
Stocks · Health care · Pharmaceutical Preparations

LB PHARMACEUTICALS INC

LBRX Clue Score33
United States Fiscal year ends December CIK 0001691082
$37.22 +7.54% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $37.22 +137.98% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 11 Sep 2025. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
Net income
Fiscal year 2024Net income−63.1EPS, diluted−176.15Fiscal year 2025Net income−25.2EPS, diluted−3.13
FY2024FY2025
Net income −63.1 −25.2
Growth
EPS, diluted −176.15 −3.13

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2024Operating cash flow−53.1Capital expenditure−0.8Free cash flow−53.8Fiscal year 2025Operating cash flow−35.2Capital expenditure−0.1Free cash flow−35.3
FY2024FY2025
Operating cash flow −53.1 −35.2
Capital expenditure −0.8 −0.1
Free cash flow −53.8 −35.3
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2024Cash23.0Shareholders’ equity−94.6Fiscal year 2025Cash250.2Shareholders’ equity301.3
FY2024FY2025
Cash 23.0 250.2
Shareholders’ equity −94.6 301.3

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Ratios

Percentages worked out from the filed figures; debt to equity in times. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2024 31 Dec 2024 FY2025 31 Dec 2025
Returns
n/a −8.4%
−188.2% −8.1%
Balance and payout
41.2% 3.7%